Peer-Based Knowledge Validation: A Hurdle to the Flow of Academic Science to Inventors
暂无分享,去创建一个
[1] Seongwuk Moon,et al. How Does the Management of Research Impact the Disclosure of Knowledge? Evidence from Scientific Publications and Patenting Behavior , 2008 .
[2] Nicola Lacetera,et al. Di¤erent Missions and Commitment Power in R&d Organization: Theory and Evidence on Industry-university Alliances , 2022 .
[3] Susan E. Cozzens,et al. Social Control and Multiple Discovery in Science: The Opiate Receptor Case. , 1989 .
[4] Philippe Aghion,et al. Academic Freedom, Private-Sector Focus, and the Process of Innovation , 2005 .
[5] Paula E. Stephan,et al. A multidimensional view of industrial and academic science , 2011 .
[6] P. David,et al. Toward a new economics of science , 1994 .
[7] D. Dougherty. Interpretive Barriers to Successful Product Innovation in Large Firms , 1992 .
[8] Diego Piccioli,et al. Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells , 2002, The Journal of experimental medicine.
[9] S. Woolgar,et al. The Manufacture of Knowledge: an Essay on the Constructivist and Contextual Nature of Science , 1982 .
[10] M. Callon. Some Elements of a Sociology of Translation: Domestication of the Scallops and the Fishermen of St Brieuc Bay , 1984 .
[11] K. Knorr-Cetina. The Manufacture of Knowledge: an Essay on the Constructivist and Contextual Nature of Science , 1985 .
[12] L. Zirulia,et al. The Economics of Scientific Misconduct , 2008 .
[13] A. Panchula,et al. Giant tunnelling magnetoresistance at room temperature with MgO (100) tunnel barriers , 2004, Nature materials.
[14] M. Heller,et al. Can Patents Deter Innovation? The Anticommons in Biomedical Research , 1998, Science.
[15] C. Haeussler. Information-Sharing in Academia and the Industry: A Comparative Study , 2010 .
[16] D. Butler. Translational research: Crossing the valley of death , 2008, Nature.
[17] V. Bush. Science, the Endless Frontier , 1999, Science, the Endless Frontier.
[18] Z. Griliches. Patent Statistics as Economic Indicators: a Survey , 1990 .
[19] M. Tushman,et al. Boundary Spanning Individuals: Their Role in Information Transfer and Their Antecedents , 1981 .
[20] Wiebe E. Bijker,et al. Science in action : how to follow scientists and engineers through society , 1989 .
[21] John P. Walsh,et al. Academic Entrepreneurship and Exchange of Scientific Resources , 2012 .
[22] Scott Shane,et al. The Halo Effect and Technology Licensing: The Influence of Institutional Prestige on the Licensing of University Inventions , 2003, Manag. Sci..
[23] R. Nelson. The Role of Knowledge in R&D Efficiency , 1982 .
[24] Lev Osherovich,et al. Hedging against academic risk , 2011 .
[25] J. Blenis,et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. , 2000, Immunity.
[26] W. Ocasio. TOWARDS AN ATTENTION-BASED VIEW OF THE FIRM , 1997 .
[27] Fiona Murray,et al. Exploring the Foundations of Cumulative Innovation: Implications for Organization Science , 2007, Organ. Sci..
[28] D. E. Stokes. Pasteur's Quadrant: Basic Science and Technological Innovation , 1997 .
[29] B. Latour,et al. Laboratory Life: The Construction of Scientific Facts , 1979 .
[30] Scott Stern,et al. Climbing Atop the Shoulders of Giants: The Impact of Institutions on Cumulative Research , 2006, American Economic Review.
[31] Jacob Schmookler,et al. Invention and Economic Growth , 1967 .
[32] Bruce Alberts. Is the Frontier Really Endless? , 2010, Science.
[33] M. Spence. Competitive and optimal responses to signals: An analysis of efficiency and distribution , 1974 .
[34] Michelle Gittelman,et al. Does Good Science Lead to Valuable Knowledge? Biotechnology Firms and the Evolutionary Logic of Citation Patterns , 2003, Manag. Sci..
[35] O. Sorenson,et al. Science and the Diffusion of Knowledge , 2001 .
[36] S. Hilgartner,et al. Data withholding in academic genetics: evidence from a national survey. , 2002, JAMA.
[37] O. Sorenson,et al. Science as a Map in Technological Search , 2000 .
[38] Fiona E. Murray. The Oncomouse That Roared: Hybrid Exchange Strategies as a Source of Distinction at the Boundary of Overlapping Institutions1 , 2010, American Journal of Sociology.
[39] Paula E. Stephan. The Economics of Science , 1996 .
[40] Michelle Gittelman,et al. Does Geography Matter for Science-Based Firms? Epistemic Communities and the Geography of Research and Patenting in Biotechnology , 2007, Organ. Sci..
[41] Giovanni Melioli,et al. Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells , 2002, The Journal of experimental medicine.
[42] Wesley M. Cohen,et al. Where excludability matters: Material versus intellectual property in academic biomedical research , 2007 .
[43] R. Nelson. The market economy, and the scientific commons , 2004 .
[44] Karim R. Lakhani,et al. Looking Across and Looking Beyond the Knowledge Frontier: Intellectual Distance, Novelty, and Resource Allocation in Science , 2016, Manag. Sci..
[45] Heidi L. Williams. Intellectual Property Rights and Innovation: Evidence from the Human Genome , 2010, Journal of Political Economy.
[46] David C. Mowery,et al. Does University Licensing Facilitate or Restrict the Flow of Knowledge and Research Inputs Among Scientists , 2014 .
[47] James A. Evans. Industry Induces Academic Science to Know Less about More1 , 2010, American Journal of Sociology.
[48] Walter W. Powell,et al. Knowledge Networks as Channels and Conduits: The Effects of Spillovers in the Boston Biotechnology Community , 2004, Organ. Sci..
[49] B. Latour. Science in action : how to follow scientists and engineers through society , 1989 .
[50] Nathan Rosenberg,et al. Incentives and Focus in University and Industrial Research: The Case of Synthetic Insulin , 1995 .
[51] M. Trajtenberg,et al. Universities as a Source of Commercial Technology: A Detailed Analysis of University Patenting, 19651988 , 1995, Review of Economics and Statistics.
[52] Suzanne K. Linder,et al. A Survey on Data Reproducibility in Cancer Research Provides Insights into Our Limited Ability to Translate Findings from the Laboratory to the Clinic , 2013, PloS one.
[53] Gary Chamberlain,et al. Analysis of Covariance with Qualitative Data , 1979 .
[54] Pierre Azoulay,et al. Do Pharmaceutical Sales Respond to Scientific Evidence , 2002 .
[55] Fiona Murray,et al. Governing knowledge in the scientific community: Exploring the role of retractions in biomedicine , 2012 .
[56] Andrew J. Nelson. How to Share "A Really Good Secret": Managing Sharing/Secrecy Tensions Around Scientific Knowledge Disclosure , 2016, Organ. Sci..
[57] Owen-SmithJason,et al. Knowledge Networks as Channels and Conduits , 2004 .
[58] M. Heller,et al. Can Patents Deter Innovation , 1998 .
[59] D. Lawrence,et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. , 2000, Immunity.
[60] S. Winter,et al. An evolutionary theory of economic change , 1983 .
[61] M. Gittelman,et al. Patent Citations as a Measure of Knowledge Flows: The Influence of Examiner Citations , 2006, The Review of Economics and Statistics.
[62] Merrill Goozner,et al. The $800 Million Pill: The Truth behind the Cost of New Drugs , 2004 .
[63] Mark A. Lemley,et al. Examiner Characteristics and Patent Office Outcomes , 2009 .
[64] Joel Mokyr,et al. The Gifts of Athena: Historical Origins of the Knowledge Economy , 2002 .
[65] Jason Owen-Smith. Managing Laboratory Work through Skepticism: Processes of Evaluation and Control , 2001, American Sociological Review.
[66] Peeter W. J. Verlegh,et al. A review and meta-analysis of country-of-origin research , 1999 .
[67] I. Cockburn,et al. Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery , 2003 .
[68] M. Rosenblatt,et al. An incentive-based approach for improving data reproducibility , 2016, Science Translational Medicine.
[69] Benjamin F. Jones. The Burden of Knowledge and the &Apos;Death of the Renaissance Man&Apos;: Is Innovation Getting Harder? , 2005 .